DermTopic: Psoriasis

Filter Your Results

 

News

 

Where is Dermatology Headed?

Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the futu…

Joel Schlessinger, MD, Neal Bhatia, MD, FAAD

UCB: Investigational Bimekizumab Helps Psoriatic Arthritis i…

Bimekizumab, in development by UCB, has shown promise for the treatment of psoriatic arthritis (PsA) in Phase 1B studies…

New Psoriasis Drug Taltz Shows Benefit Through 60 Weeks

Three new studies demonstrate the efficacy and safety of Eli Lilly's Taltz® (ixekizumab) through 60 we…

Sernivo Spray Hits Pharmacy Shelves

Sernivo™ Spray for psoriasis is officially available. Dr. Reddy’s Laboratories’ US subsidiary, Prom…

Target: PASI 90

With new advancements in biologic therapy, patients are gaining more control of psoriasis. Whereas PASI 50 was once seen…

Jashin J. Wu, MD

AXIM Biotech Begins Clinical Trials With Cannabigerol for P…

AXIM Biotechnologies, Inc. launched human dermatological clinical trials based on its proprietary, patent-pending topica…

The New Thinking on Psoriasis

A growing and convincing body of evidence links psoriasis to a host of emotional, psychiatric, and systemic comorbiditie…

Jerry Bagel, MD

Is Eli Lilly’s Taltz the Next Blockbuster Drug for Psorias…

Eli Lilly’s new psoriasis drug Taltz (ixekizumab) is set to generate sales in excess of $1 billion in the US and E…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.